Molecular Templates' Reverse Merger Round

Molecular Templates raised a round of funding on March 17, 2017. Investors include Threshold Pharmaceuticals.

Molecular Templates is a biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapeutics with advantages over existing Antibody Drug Conjugates (ADC…

Articles about Molecular Templates' Reverse Merger Round: